Skip to main content

Table 2 Adverse and severe adverse events of OA patients after Re-Join® and HA treatment (n = 52)

From: Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial

Group

Number of patients

Number of injections

AEs, n

SAEs, n

Frequency of AE (%)

Frequency of SAEs (%)

P value

HA

26

104

14

1

53.85

3.846

0.1144

Re-Join@

26

103

19

0

73.07

0

 

Total

52

207

33

1

63.46

1.92

 
  1. AE adverse event, SAE serious adverse events